Recent Advances in Interventional Oncology
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 74
Special Issue Editors
2. Director Post-Graduate School of Nuclear Medicine, Milan, Italy
3. Director of Diagnostic and Interventional Radiology, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
Interests: diagnostic and interventional radiology; interventional oncology; vascular radiology
Special Issue Information
Dear Colleagues,
Interventional oncology (IO) is the most recent and fastest growing sub-specialty of interventional radiology, dedicated to the treatment and palliation of cancer and cancer-related symptoms. IO is based on minimally invasive procedures performed percutaneously or endovascularly under image guidance. IO has established itself as an emerging therapeutic specialty within multidisciplinary oncology care, and together with medical, surgical, and radiation oncology, it is today considered the fourth pillar of modern oncological care. IO is focused on three main areas in cancer management: diagnosis, therapy, and symptom palliation.
Currently, the top cause of death worldwide is cancer, surpassing cardiovascular disorders. In modern medicine, there is a growing demand for faster, increasingly individualized, and more affordable health care solutions. IO is a technology-driven, minimally invasive specialty that is able to deliver personalized procedures.
Different innovative technologies have been introduced in recent years with the aim of improving the performance of IO procedures. Artificial intelligence, including radiomics, virtual reality, robotics, and fusion imaging, has recently been introduced in clinical practice. Significant advances in imaging technology have allowed image-guided procedures to be brought into daily clinical practice, which has made targeted cancer treatment possible.
Moreover, the combination of IO and immunotherapy is showing promising results and a significant amount of interest is focused on improving this combination, looking forward to its full implementation in clinical practice.
The purpose of this Special Issue is to cover recent advances in interventional radiology by collecting papers that make full use of easy-to-understand new technologies and trends in IO.
Prof. Dr. Gianpaolo Carrafiello
Dr. Carolina Lanza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- interventional radiology
- image-guided diagnosis
- radiomics
- cancer diagnosis and treatment
- fusion imaging
